Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Regulatory Filings 2017

May 31, 2017

30198_rns_2017-05-31_21c696bc-12a7-45c5-ac00-f4b68c8d3145.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM SD

SPECIALIZED DISCLOSURE REPORT

DEXCOM, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware 000-51222 33-0857544
(State or other jurisdiction of incorporation or organization ) (Commission File Number) (IRS Employer Identification No.)

6340 Sequence Drive, San Diego, California 92121

(Address of Principal Executive Offices) (Zip Code)

Kevin Sun

(858) 200-0200

(Name and telephone number, including area code, of the person to contact in connection with this report.)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

x Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period January 1 to December 31, 2016

Item 1.01. Conflict Minerals Disclosure and Report.

Conflict Minerals Disclosure

A copy of the Conflict Minerals Report of DexCom, Inc. (“DexCom”) for the reporting period January 1 to December 31, 2016 is filed as Exhibit 1.01 to this specialized disclosure report on Form SD and is also available at DexCom’s website at http://investor.shareholder.com/dexcom/sec.cfm.

Item 1.02. Exhibit.

DexCom has filed, as an exhibit to this Form SD, a Conflict Minerals Report as required by Item 1.01 of this Form.

Exhibit Number Description of Document
1.01 DexCom, Inc. Conflict Minerals Report for the reporting period January 1 to December 31, 2016.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

By: DEXCOM, INC. — /s/ Kevin Sun____
Name: Kevin Sun
Title: Vice President & Interim Chief Financial Officer

EXHIBIT INDEX

Exhibit Number Description of Document

1.01 DexCom, Inc. Conflict Minerals Report for the reporting period January 1 to December 31, 2016.